Canagliflozin

Product name:Canagliflozin
CAS:842133-18-0
Molecular Formula: C24H25FO5S
Molecular Weight : 444.52
Purity: >99%
Appearance: white powder
Product description:
Canagliflozin (INN, trade name Invokana) is a drug for the treatment of type 2 diabetes. It was developed by Mitsubishi Tanabe Pharma and is marketed under license by Janssen, a division of Johnson & Johnson. Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein(SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine.